Kandi Technologies Group (NASDAQ:KNDI) reported quarterly losses of $(0.10) per share. This is a 233.33 percent decrease over losses of $(0.03) per share from the same period last year. The company reported $16.80 million in sales this quarter. This is a 10.27 percent decrease over sales of $18.72 million the same period last year.
Mizuho Maintains Buy on Coherus BioSciences, Lowers Price Target to $25
Mizuho analyst Salim Syed maintains Coherus BioSciences (NASDAQ:CHRS) with a Buy and lowers the price target from $30 to $25.
